Inactive Instrument

Monterey Innovation Acquisition Corp.

MTRY

US61240F1084

Monterey Bio Acquisition Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022

August 11, 2022 at 09:14 pm

Monterey Bio Acquisition Corporation reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported net loss was USD 0.188866 million.
For the six months, net loss was USD 0.546264 million compared to USD 0.000025 million a year ago.

Latest news about Monterey Innovation Acquisition Corp.

Monterey Innovation Acquisition Corp.(NasdaqGM:MTRY) dropped from NASDAQ Composite Index	11-20	CI
Monterey Innovation Acquisition Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	22/08/23	CI
Monterey Innovation Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023	18/05/23	CI
Monterey Bio Acquisition Corporation Reports Earnings Results for the Full Year Ended December 31, 2022	17/04/23	CI
Monterey Innovation Acquisition Corp. Auditor Raises 'Going Concern' Doubt	16/04/23	CI
Monterey Bio Acquisition to Change Name to Monterey Innovation Acquisition	10/03/23	MT
Monterey Bio Acquisition Corporation Announces Board Changes	10/03/23	CI
Monterey Bio Acquisition Corporation Appoints Murat Omur as Chief Executive Officer	10/03/23	CI
Monterey Bio Acquisition Corporation Appoints Sean McGann as Chief Financial Officer	10/03/23	CI
Monterey Bio Acquisition Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	10/11/22	CI
Monterey Innovation Acquisition Corp. announced that it expects to receive $0.7 million in funding from Northstar Bio Ventures, LLC, Chardan Monterey Investments LLC	06/10/22	CI
Monterey Bio Acquisition Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	11/08/22	CI
Monterey Bio Acquisition Corporation Reports Earnings Results for the First Quarter Ended March 31, 2022	13/05/22	CI
Certain Common Stock of Monterey Bio Acquisition Corporation are subject to a Lock-Up Agreement Ending on 30-MAR-2022.	29/03/22	CI
Monterey Bio Acquisition Corporation Reports Earnings Results for the Full Year Ended December 31, 2021	29/03/22	CI
Monterey Bio Acquisition Corporation Auditor Raises 'Going Concern' Doubt	28/03/22	CI
Monterey Bio Acquisition Corporation(NasdaqGM:MTRY) added to NASDAQ Composite Index	23/11/21	CI
Monterey Bio Acquisition Corporation has completed an IPO in the amount of $100 million.	30/09/21	CI
Monterey Bio Acquisition Corporation has filed an IPO in the amount of $100 million.	07/09/21	CI

Chart Monterey Innovation Acquisition Corp.

Duration

Period

Chart Monterey Innovation Acquisition Corp.

More charts

Company Profile

Monterey Innovation Acquisition Corp., formerly Monterey Bio Acquisition Corp., is a blank check company. The Company is formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more businesses or entities. The Company intends to focus its efforts on identifying a disruptive technology company.

Sector

Investment Holding Companies

More about the company

Sector Shell Companies

	1st Jan change	Capi.
SCREAMING EAGLE ACQUISITION CORP.	-3.96%	1.04B
OKLO INC.	-7.48%	1.03B
CHURCHILL CAPITAL CORP VII	+2.10%	982M
APPLE ISPORTS GROUP, INC.	+41.91%	872M
PERELLA WEINBERG PARTNERS	+22.32%	814M
E7 GROUP	+8.62%	675M
ARES ACQUISITION CORPORATION II	+1.77%	664M
DA ZHONG TRADING GROUP HOLDING COMPANY	+0.00%	600M
ADMIRAL ACQUISITION LIMITED	+3.61%	503M

Shell Companies